RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Metabiomed Co Stock

Metabiomed Co Debt 2024

Metabiomed Co Debt

33,651.68 KRW

Ticker

059210.KQ

ISIN

KR7059210005

In 2024, Metabiomed Co's total debt was 33,651.68 KRW, a 9.1% change from the 30,845.47 KRW total debt recorded in the previous year.

Metabiomed Co Aktienanalyse

What does Metabiomed Co do?

Metabiomed Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Metabiomed Co's Debt Structure

Metabiomed Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Metabiomed Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Metabiomed Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Metabiomed Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Metabiomed Co stock

What is the debt of Metabiomed Co this year?

Metabiomed Co has a debt level of 33,651.68 KRW this year.

What was the debt of Metabiomed Co compared to the previous year?

The debt of Metabiomed Co has increased by 9.1% compared to the previous year increased.

What are the consequences of high debt for investors in Metabiomed Co?

High debt can pose a risk for investors of Metabiomed Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Metabiomed Co?

Low debt means that Metabiomed Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Metabiomed Co affect the company?

An increase in debt of Metabiomed Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Metabiomed Co affect the company?

A reduction in debt of Metabiomed Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Metabiomed Co?

Some factors that can influence the debt of Metabiomed Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Metabiomed Co so important for investors?

The debts of Metabiomed Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Metabiomed Co take to change the debt?

To change the debt, Metabiomed Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Metabiomed Co pay?

Over the past 12 months, Metabiomed Co paid a dividend of 20 KRW . This corresponds to a dividend yield of about 0.52 %. For the coming 12 months, Metabiomed Co is expected to pay a dividend of 20 KRW.

What is the dividend yield of Metabiomed Co?

The current dividend yield of Metabiomed Co is 0.52 %.

When does Metabiomed Co pay dividends?

Metabiomed Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Metabiomed Co?

Metabiomed Co paid dividends every year for the past 16 years.

What is the dividend of Metabiomed Co?

For the upcoming 12 months, dividends amounting to 20 KRW are expected. This corresponds to a dividend yield of 0.52 %.

In which sector is Metabiomed Co located?

Metabiomed Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Metabiomed Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Metabiomed Co from 4/15/2024 amounting to 20 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Metabiomed Co pay the last dividend?

The last dividend was paid out on 4/15/2024.

What was the dividend of Metabiomed Co in the year 2023?

In the year 2023, Metabiomed Co distributed 20 KRW as dividends.

In which currency does Metabiomed Co pay out the dividend?

The dividends of Metabiomed Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Metabiomed Co

Our stock analysis for Metabiomed Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Metabiomed Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.